EVA is registered trademark of Stern Stewart.
Economic value added or economic profit is the difference between revenues and costs,where costs include not only expenses, but also cost of capital.
Economic Profit
Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31).
1 NOPAT. See details »
2 Cost of capital. See details »
3 Invested capital. See details »
4 2021 Calculation
Economic profit = NOPAT – Cost of capital × Invested capital
= 2,015 – 12.30% × 26,516 = -1,247
Item | Description | The company |
---|---|---|
Economic profit | Economic profit is a measure of corporate performance computed by taking the spread between the return on invested capital and the cost of capital, and multiplying by the invested capital. | Stryker Corp. economic profit decreased from 2019 to 2020 but then slightly increased from 2020 to 2021. |
Net Operating Profit after Taxes (NOPAT)
Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31).
1 Elimination of deferred tax expense. See details »
2 Addition of increase (decrease) in allowance for doubtful accounts.
3 Addition of increase (decrease) in equity equivalents to net earnings.
4 2021 Calculation
Interest expense on capitalized operating leases = Operating lease liability × Discount rate
= 422 × 2.86% = 12
5 2021 Calculation
Tax benefit of interest expense = Adjusted interest expense × Statutory income tax rate
= 349 × 21.00% = 73
6 Addition of after taxes interest expense to net earnings.
7 2021 Calculation
Tax expense (benefit) of investment income = Investment income, before tax × Statutory income tax rate
= 68 × 21.00% = 14
8 Elimination of after taxes investment income.
Item | Description | The company |
---|---|---|
NOPAT | Net operating profit after taxes is income from operations, but after removement of taxes calculated on cash basis that are relevant to operating income. | Stryker Corp. NOPAT decreased from 2019 to 2020 but then slightly increased from 2020 to 2021. |
Cash Operating Taxes
Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31).
Item | Description | The company |
---|---|---|
Cash operating taxes | Cash operating taxes are estimated by adjusting income tax expense for changes in deferred taxes and tax benefit from the interest deduction. | Stryker Corp. cash operating taxes decreased from 2019 to 2020 but then increased from 2020 to 2021 exceeding 2019 level. |
Invested Capital
Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31).
1 Addition of capitalized operating leases.
2 Elimination of deferred taxes from assets and liabilities. See details »
3 Addition of allowance for doubtful accounts receivable.
4 Addition of equity equivalents to total Stryker shareholders’ equity.
5 Removal of accumulated other comprehensive income.
6 Subtraction of marketable securities.
Item | Description | The company |
---|---|---|
Invested capital | Capital is an approximation of the economic book value of all cash invested in going-concern business activities. | Stryker Corp. invested capital increased from 2019 to 2020 but then slightly decreased from 2020 to 2021. |
Cost of Capital
Stryker Corp., cost of capital calculations
Capital (fair value)1 | Weights | Cost of capital | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity2 | 95,009) | 95,009) | ÷ | 108,832) | = | 0.87 | 0.87 | × | 13.82% | = | 12.07% | ||
Debt3 | 13,401) | 13,401) | ÷ | 108,832) | = | 0.12 | 0.12 | × | 2.33% × (1 – 21.00%) | = | 0.23% | ||
Operating lease liability4 | 422) | 422) | ÷ | 108,832) | = | 0.00 | 0.00 | × | 2.86% × (1 – 21.00%) | = | 0.01% | ||
Total: | 108,832) | 1.00 | 12.30% |
Based on: 10-K (reporting date: 2021-12-31).
1 US$ in millions
2 Equity. See details »
3 Debt. See details »
4 Operating lease liability. See details »
Capital (fair value)1 | Weights | Cost of capital | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity2 | 92,297) | 92,297) | ÷ | 108,169) | = | 0.85 | 0.85 | × | 13.82% | = | 11.79% | ||
Debt3 | 15,438) | 15,438) | ÷ | 108,169) | = | 0.14 | 0.14 | × | 2.32% × (1 – 21.00%) | = | 0.26% | ||
Operating lease liability4 | 434) | 434) | ÷ | 108,169) | = | 0.00 | 0.00 | × | 2.57% × (1 – 21.00%) | = | 0.01% | ||
Total: | 108,169) | 1.00 | 12.06% |
Based on: 10-K (reporting date: 2020-12-31).
1 US$ in millions
2 Equity. See details »
3 Debt. See details »
4 Operating lease liability. See details »
Capital (fair value)1 | Weights | Cost of capital | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity2 | 81,747) | 81,747) | ÷ | 94,070) | = | 0.87 | 0.87 | × | 13.82% | = | 12.01% | ||
Debt3 | 11,936) | 11,936) | ÷ | 94,070) | = | 0.13 | 0.13 | × | 2.63% × (1 – 21.00%) | = | 0.26% | ||
Operating lease liability4 | 387) | 387) | ÷ | 94,070) | = | 0.00 | 0.00 | × | 3.34% × (1 – 21.00%) | = | 0.01% | ||
Total: | 94,070) | 1.00 | 12.29% |
Based on: 10-K (reporting date: 2019-12-31).
1 US$ in millions
2 Equity. See details »
3 Debt. See details »
4 Operating lease liability. See details »
Capital (fair value)1 | Weights | Cost of capital | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity2 | 67,359) | 67,359) | ÷ | 77,539) | = | 0.87 | 0.87 | × | 13.82% | = | 12.01% | ||
Debt3 | 9,872) | 9,872) | ÷ | 77,539) | = | 0.13 | 0.13 | × | 3.09% × (1 – 21.00%) | = | 0.31% | ||
Operating lease liability4 | 308) | 308) | ÷ | 77,539) | = | 0.00 | 0.00 | × | 3.09% × (1 – 21.00%) | = | 0.01% | ||
Total: | 77,539) | 1.00 | 12.33% |
Based on: 10-K (reporting date: 2018-12-31).
1 US$ in millions
2 Equity. See details »
3 Debt. See details »
4 Operating lease liability. See details »
Capital (fair value)1 | Weights | Cost of capital | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity2 | 55,451) | 55,451) | ÷ | 63,303) | = | 0.88 | 0.88 | × | 13.82% | = | 12.11% | ||
Debt3 | 7,556) | 7,556) | ÷ | 63,303) | = | 0.12 | 0.12 | × | 3.22% × (1 – 35.00%) | = | 0.25% | ||
Operating lease liability4 | 296) | 296) | ÷ | 63,303) | = | 0.00 | 0.00 | × | 3.22% × (1 – 35.00%) | = | 0.01% | ||
Total: | 63,303) | 1.00 | 12.37% |
Based on: 10-K (reporting date: 2017-12-31).
1 US$ in millions
2 Equity. See details »
3 Debt. See details »
4 Operating lease liability. See details »
Economic Spread Ratio
Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | ||
---|---|---|---|---|---|---|
Selected Financial Data (US$ in millions) | ||||||
Economic profit1 | (1,247) | (1,406) | (512) | (462) | (978) | |
Invested capital2 | 26,516) | 27,132) | 23,274) | 20,767) | 17,502) | |
Performance Ratio | ||||||
Economic spread ratio3 | -4.70% | -5.18% | -2.20% | -2.22% | -5.59% | |
Benchmarks | ||||||
Economic Spread Ratio, Competitors4 | ||||||
Abbott Laboratories | 0.66% | -2.61% | -3.93% | — | — | |
Cigna Group | -0.21% | 2.68% | -0.53% | — | — | |
CVS Health Corp. | -0.03% | 0.42% | -0.36% | — | — | |
Elevance Health Inc. | 1.08% | -0.90% | -0.07% | — | — | |
Humana Inc. | 2.69% | 9.55% | 7.68% | — | — | |
Intuitive Surgical Inc. | 20.60% | 8.59% | 25.27% | — | — | |
Medtronic PLC | -4.49% | -3.60% | -2.52% | — | — | |
UnitedHealth Group Inc. | 4.57% | 5.14% | 5.17% | — | — |
Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31).
1 Economic profit. See details »
2 Invested capital. See details »
3 2021 Calculation
Economic spread ratio = 100 × Economic profit ÷ Invested capital
= 100 × -1,247 ÷ 26,516 = -4.70%
4 Click competitor name to see calculations.
Performance ratio | Description | The company |
---|---|---|
Economic spread ratio | The ratio of economic profit to invested capital, also equal to the difference between return on invested capital (ROIC) and cost of capital. | Stryker Corp. economic spread ratio deteriorated from 2019 to 2020 but then slightly improved from 2020 to 2021. |
Economic Profit Margin
Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | ||
---|---|---|---|---|---|---|
Selected Financial Data (US$ in millions) | ||||||
Economic profit1 | (1,247) | (1,406) | (512) | (462) | (978) | |
Net sales | 17,108) | 14,351) | 14,884) | 13,601) | 12,444) | |
Performance Ratio | ||||||
Economic profit margin2 | -7.29% | -9.80% | -3.44% | -3.40% | -7.86% | |
Benchmarks | ||||||
Economic Profit Margin, Competitors3 | ||||||
Abbott Laboratories | 0.95% | -4.55% | -7.16% | — | — | |
Cigna Group | -0.11% | 1.58% | -0.32% | — | — | |
CVS Health Corp. | -0.01% | 0.21% | -0.20% | — | — | |
Elevance Health Inc. | 0.50% | -0.43% | -0.04% | — | — | |
Humana Inc. | 0.99% | 2.74% | 2.25% | — | — | |
Intuitive Surgical Inc. | 16.21% | 8.81% | 18.73% | — | — | |
Medtronic PLC | -10.76% | -8.87% | -5.98% | — | — | |
UnitedHealth Group Inc. | 2.24% | 2.62% | 2.52% | — | — |
Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31).
1 Economic profit. See details »
2 2021 Calculation
Economic profit margin = 100 × Economic profit ÷ Net sales
= 100 × -1,247 ÷ 17,108 = -7.29%
3 Click competitor name to see calculations.
Performance ratio | Description | The company |
---|---|---|
Economic profit margin | The ratio of economic profit to sales. It is the company profit margin covering income efficiency and asset management. Economic profit margin is not biased in favor of capital-intensive business models, because any added capital is a cost to the economic profit margin. | Stryker Corp. economic profit margin deteriorated from 2019 to 2020 but then slightly improved from 2020 to 2021. |